Skip to content

Capital World Investors: DUOL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital World Investors on DUOL, newest first. How the timeline and the estimate are built.

Capital World Investors held 0 DUOL shares at 2026-03-31 per its 13F-HR filed 2026-05-13.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -2,241,378 shares

    13F-HR 0001422849-26-000046 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 2,241,378 shares
    Change vs previous 13F +11,140 shares

    0.05% of the 13F portfolio, value $393,361,770.

    13F-HR 0001422849-26-000010 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 2,230,238 shares
    Change vs previous 13F -62,514 shares

    0.1% of the 13F portfolio, value $717,788,728.

    13F-HR 0001422849-25-000069 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 2,292,752 shares
    Change vs previous 13F +936,956 shares

    0.14% of the 13F portfolio, value $940,075,655.

    13F-HR 0001422848-25-000151 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 1,355,796 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $421,028,890.

    13F-HR 0000732812-25-000016 filed by Capital World Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).